The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd

Promoter pledge above 50%Ownership Changes View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹399.20

prior close

₹398.50

announcement price

In-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%+0.5% vs market

Healthcare Service Provider peers, median of 22sector-0.6%+1.5% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.5 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

+0.0

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.4+0.5-0.6+1.5

Next day

+2.2-0.4+2.6+0.3+2.0

+0.9-0.7+1.5+0.0+0.8

+1.2-1.0+2.2+0.5+0.7

-0.1-2.1+2.0-1.0+0.9

-6.1-4.2-1.9-2.6-3.5

-3.6-5.3+1.8-2.4-1.1

15d

+6.4-3.2+9.6-3.6+10.1

+3.8-2.3+6.1-4.3+8.1

+30.2-2.9+33.0-7.6+37.8

+9.3-7.6+16.9-15.5+24.8

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Catalyst Trusteeship Ltd, acting as Debenture Trustee, has disclosed the creation of a pledge on 3,23,23,232 equity shares of Thyrocare Technologies, representing 60.99% of the company's total share capital. The pledgor is Docon Technologies Private Limited, the promoter and holding company of Thyrocare, and the pledge is created to secure new debentures issued by API Holdings Ltd, the ultimate holding company. This is not an acquisition of voting shares but an encumbrance (pledge) created on September 17, 2025. The shares remain under encumbrance post-transaction at the same 60.99% level.

Likely market impact

Over 60% of Thyrocare's shares now stand pledged by the promoter group to secure parent-level (API Holdings) borrowings, which raises governance and financial risk concerns for retail shareholders as any default at the holding company level could trigger invocation of the pledge and potential change in ownership.